3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
64
Leukemia
63
Precursor Cell Lymphoblastic Leukemia-Lymphoma
62
Myelodysplastic Syndromes
56
Leukemia, Lymphocytic, Chronic, B-Cell
54
Multiple Myeloma
49
Lymphoma, Non-Hodgkin
49
Hodgkin Disease
47
Lymphoma, Mantle-Cell
41
Lymphoma, Large B-Cell, Diffuse
39
Lymphoma, Follicular
39
Leukemia, Myeloid, Chronic-Phase
39
Lymphoma, B-Cell, Marginal Zone
35
Lymphoma
35
Burkitt Lymphoma
35
Lymphoma, Large-Cell, Immunoblastic
34
Myeloproliferative Disorders
33
Congenital Abnormalities
32
Leukemia, Myeloid, Accelerated Phase
31
Anemia, Refractory, with Excess of Blasts
30
Leukemia, Myelomonocytic, Chronic
28
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
24
Dendritic Cell Sarcoma, Interdigitating
23
Blast Crisis
23
Waldenstrom Macroglobulinemia
21
Recurrence
21
Lymphoma, T-Cell, Cutaneous
20
Anemia, Refractory
19
Sezary Syndrome
18
Graft vs Host Disease
18
Interventions
Brentuximab Vedotin
17
fludarabine
9
Cyclophosphamide
9
dacetuzumab
6
Lenalidomide
6
Bortezomib
6
ruxolitinib
5
fludarabine phosphate
5
Rituximab
5
Melphalan
5
Dexamethasone
4
Busulfan
4
lintuzumab
3
Whole-Body Irradiation
3
Mycophenolic Acid
3
Imatinib Mesylate
3
Granulocyte Colony-Stimulating Factor
3
Doxorubicin
3
Calcium Dobesilate
3
Azacitidine
3
vosaroxin
2
spartalizumab
2
ponatinib
2
nilotinib
2
Vincristine
2
Thiotepa
2
Tacrolimus
2
Sugars
2
Stem Cell Transplantation
2
Rifampin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hematologic Diseases
×
Cyclosporine
×
Clear all
NCT00636909
2017-04-06
MINI HEME
Beth Israel Deaconess Medical Center
Phase 2
Completed
25 enrolled